craniopharyngioma
craniopharyngioma
Explore linked clinical trials. Standard reference: MONDO:001890725 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FOG-001 in Locally Advanced or Metastatic Solid Tumors | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adamantinous craniopharyngioma, adenocarcinoma, adenoma, cancer, carcinoma, classic familial adenomatous polyposis, colonic disorder, colorectal cancer, colorectal neoplasm, connective tissue neoplasm, craniopharyngioma, desmoid tumor, digestive system disorder, digestive system neoplasm, endometrial carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, fibroma, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, liver disorder, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, neoplasm, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rectal disorder, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT05919264 | |
| Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, papillary craniopharyngioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-10-07 | NCT03224767 | |
| SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniopharyngioma, Child, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Abnormalities, Urogenital Diseases, craniopharyngioma, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism, neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 3 | 2026-09-29 | NCT07845994 | |
| A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not applicable | 2026-09-22 | NCT07835165 | |
| A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, central nervous system cancer, central nervous system disorder, craniopharyngioma, neoplasm, nervous system disorder, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-09-22 | NCT02792582 | |
| China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Rathke Cleft Cysts, brain disorder, central nervous system cancer, central nervous system cyst, central nervous system disorder, central nervous system malformation, chordoma, craniopharyngioma, germinoma, hypothalamic disorder, hypothalamic neoplasm, meningioma, neoplasm, nervous system disorder, optic pathway glioma, primitive neuroectodermal tumor, supratentorial cancer, tumor of meninges, vascular cancer | Not yet recruiting | Not stated | 2026-09-09 | NCT07809178 | |
| A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-08-19 | NCT01419067 | |
| AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors | Choroid Plexus Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, brain disorder, central nervous system cancer, central nervous system disorder, cerebral ventricle cancer, craniopharyngioma, ependymoma, epithelial neoplasm, glioma, medulloblastoma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not stated | 2026-07-23 | NCT07703605 | |
| Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Enrolling by invitation | Phase 4 | 2026-07-17 | NCT07712328 | |
| Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pituitary Neoplasms, brain disorder, central nervous system cancer, central nervous system disorder, craniopharyngioma, endocrine system disorder, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland adenoma, pituitary gland disorder, primitive neuroectodermal tumor, supratentorial cancer | Recruiting | Not applicable | 2026-06-30 | NCT07316101 | |
| Methionine PET/CT Studies In Patients With Cancer | Ewing sarcoma, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, brain stem glioma, connective tissue neoplasm, craniopharyngioma, ependymoma, epithelial neoplasm, glioma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, medulloblastoma, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, non-Hodgkin lymphoma, osteosarcoma, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma | Active, not recruiting | Phase 2 | 2026-06-17 | NCT00840047 | |
| Long-Term Longitudinal QoL in Patients Undergoing EEA | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Esthesioneuroblastoma, Olfactory, Hernia, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pituitary Neoplasms, Rathke Cleft Cysts, brain disorder, central nervous system cancer, central nervous system cyst, central nervous system disorder, central nervous system malformation, cephalocele, chondrosarcoma, chordoma, connective tissue neoplasm, cranial nerve neuropathy, craniopharyngioma, endocrine system disorder, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, pituitary gland disorder, primitive neuroectodermal tumor, sarcoma, supratentorial cancer, tumor of meninges, vascular cancer | Active, not recruiting | Not stated | 2026-05-20 | NCT04087902 | |
| Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults | Craniopharyngioma, Child, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-23 | NCT05465174 | |
| ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-23 | NCT05233397 | |
| MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-08 | NCT05286788 | |
| Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy | Craniopharyngioma, Child, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Enrolling by invitation | Not stated | 2026-03-23 | NCT03610906 | |
| Food Preferences and Craniopharyngiomas | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not stated | 2026-02-23 | NCT07301554 | |
| Tocilizumab in Children With ACP | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Early phase 1 | 2026-02-17 | NCT03970226 | |
| Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2025-11-18 | NCT06970145 | |
| ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, craniopharyngioma, disease, neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2025-09-17 | NCT07177482 | |
| Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Abnormalities, Urogenital Diseases, brain disorder, central nervous system cancer, central nervous system disorder, craniopharyngioma, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism, hypothalamic disorder, hypothalamic neoplasm, neoplasm, nervous system disorder, primitive neuroectodermal tumor, supratentorial cancer | Recruiting | Phase 2 | 2025-07-28 | NCT06299891 | |
| The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pituitary Neoplasms, brain disorder, central nervous system cancer, central nervous system disorder, craniopharyngioma, endocrine system disorder, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, meningioma, neoplasm, nervous system disorder, pituitary gland adenoma, pituitary gland disorder, primitive neuroectodermal tumor, supratentorial cancer, tumor of meninges, vascular cancer | Recruiting | Not stated | 2025-04-23 | NCT06874426 | |
| Craniopharyngioma and Pregnancies | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2025-04-02 | NCT06801756 | |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenoma, astrocytoma (excluding glioblastoma), central nervous system cancer, cranial nerve neoplasm, cranial nerve neuropathy, craniopharyngioma, ependymoma, epithelial neoplasm, eye disorder, ganglioglioma, germinoma, glioma, hemangiopericytoma, meningioma, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroepithelial neoplasm, neuroma, neuromuscular disease, oligodendroglioma, optic nerve disorder, optic nerve glioma, optic nerve neoplasm, peripheral nervous system disorder, peripheral nervous system neoplasm, primitive neuroectodermal tumor, schwannoma, tumor of meninges, vascular cancer | Recruiting | Not stated | 2024-11-26 | NCT04648462 | |
| Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-02-14 | NCT05525273 |